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Introduction 
Every year trauma together with bone, joints and cartilage-associated diseases 
usually involve structural damage, resulting in a severe pain and disability for millions of 
people worldwide[1]. In regenerative medicine, cellular, tissue and organ-based approaches 
are developed to restore biological functions that have been lost[2],[3]. Therefore, tissue 
repair and regenerative medicine have attracted the interest of the scientific community, 
providing promising results in preclinical models and clinical pilot studies.  
Different cells such as mesenchymal stem cells (MSCs) are crucial players in the 
processes of tissue regeneration. MSCs are progenitor cells that can be differentiated into 
many cell types and also have the ability to migrate towards damaged tissues[4] (i.e., 
wounds, tumor sites, inflamed tissues) to help in their repair. Promising results using these 
cells have already been reported in wound healing, for example in repairing corneal 
damage[5] or spinal cord injury[6]. Skeletal disorders present many opportunities for the use 
of MSCs, and numerous clinical trials have shown encouraging results[7]. These cells 
present a high potential in regenerative medicine where novel therapeutic strategies could 
be developed, based on different chemical and biological cues.  
Nanotechnological tools have often been leveraged for tissue regeneration 
because some nanoscale properties make cell interactions and other cellular functions 
(cell adhesion, proliferation and differentiation) far more efficient than traditional 
macroscopic materials[8]. The capacity of some nanomaterials to speed up the repair of 
several tissues (such as bone, cartilage, bladder, nerves and vessels) by improving their 
intrinsic biological functions has been reported[9]. The quantification of the migration 
ability and proliferative capacity of cells on different substrates provide valuable insights 
for new biomaterials design[10]. Numerous in vitro and in vivo reports have studied the 
effect of nanoparticles (characteristics such as sizes[11], shapes[12] and surface coatings[13]) 
in cell migration, proliferation, differentiation and wound healing. For example, 
internalization of SiO2 Nanoparticles (NPs) affect essential physiological functions in the 
cell including adhesion and migration[14]. In the same way, it has been demonstrated that 
the human endothelial exposition to carbon nanotubes induces an increase in endothelial 
monolayer permeability and cell migration[15]. Also the effects of TiO2, SiO2 and 
hydroxyapatite NPs in epithelial cell migration have been evaluated, resulting in an 
increased cell contractility with significantly impaired wound healing capability[16]. Finally, 
the use of PLGA micro-NPs to promote bone regeneration has also been analyzed. In this 
sense, the use of PLGA micro-NPs could be an advance in the design of scaffolds, since it 
allows the encapsulation of inducing bone regeneration growth factors as BMP2. In 
addition PLGA is biocompatible and biodegradable, which give it advantages over other 
materials[17]. 
Gold nanoparticles (GNPs) have attracted the interest of recent research because 
of their biomedical potential as drug carriers, gene vectors and therapeutic agents in a 
wide range of promising applications ranging from cancer and neuropsychiatric disorders 
to tissue repair and regeneration[18]. Their advantages include the ease of synthesis in a 
varied range of monodisperse sizes, the fact that they are essentially inert and non-toxic at 
the doses used and their ability to be readily functionalized with targeting ligands and 
drugs. Recent studies indicate that these nanoscale materials have a direct influence on 
MSCs behavior from a cellular to a molecular level. Thus, GNPs functionalized with 
different coatings induce differential MSC response and, when optimized, could promote 
MSCs proliferation, contributing to the development of new strategies for tissue 
regeneration therapies[19].  
Here we report the potential impact of GNPs on the migration and proliferation 
behavior of different cell lines: MSCs, HeLa cells and human dermal fibroblasts. GNPs are 
easily internalized by MSCs causing an increase in their migration rate, mediated by actin 
and tubulin expression. On the other hand, the migration capacity of tumoral and 
epithelial cells was not significantly affected by the presence of the nanoparticles at the 
same doses. Our results provide some insights on the influence of GNPs on cellular 
behavior (migration, proliferation, differentiation and ability to colonize scaffolds) and 
show the potential of these materials for strategic regenerative medicine and tissue repair. 
Incubation of MSCs with GNPs appears as a useful tool to modulate their migration 
capacity to achieve a more rapid and effective regenerative therapy. 
Methods 
1. Synthesis of Hollow Gold Nanoparticles 
All the materials employed in the HGNs synthesis were provided by Sigma Aldrich and 
used as received: cobalt (II) chloride hexahydrate, sodium citrate tribasic dihydrate, poly 
(vinylpyrrolidone) (PVP) Mw=55000 Da, gold (III) chloride hydrate (50% purity), sodium 
borohydride, and poly (ethylene glycol)-ether thiol (PEG 1000 Da MW). 
HGNs synthesis was carried out following the procedure used in previous works[20]. Briefly, 
in a two-necked round-bottom flask 400 mL of distilled water, 400 μL of 0.4 M of cobalt 
chloride hexahydrate (CoCl2·6H2O) and 1.6 mL of 0.1 M sodium citrate trihydrate 
(Na3C6H5O7·3H2O) were mixed without magnetic stirring under an inert Ar atmosphere to 
avoid a premature Co oxidation. After 40 minutes, 2 mL of a 1 wt. % solution of poly 
(vinylpyrrolidone) (PVP) with an average Mw of 55000 Da and 400 µL of 1.0 M sodium 
borohydride (NaBH4) were added. The color change from pale pink to brown was 
indicative of the cobalt nanoparticle formation. Subsequently, 120 mL of distilled water 
and 180 µL of 0.1M chloroauric acid trihydrate (HAuCl4·3H2O) were mixed with 360 mL of 
the previous cobalt-based dispersion used as sacrificial template to promote the formation 
of CoCl2, CoO and the and the galvanic reduction of Au3+ obtaining hollow Au-based shells.  
The resulting HGNs were functionalized with PEG (steric polymer) to obtain PEG-HGNs 
using an excess of monofunctional poly (ethylene glycol)-ether thiol (PEG 1000 Da MW), 
taking advantage of the strong chemical bond between Au and S. A solution of HGNs was 
put in contact with a dilution of PEG during one hour under magnetic stirring. Any excess 
of unbound PEG was removed by dialysis. 
The concentration of the final dispersion was adjusted by centrifugation at 10000 rpm for 
10 minutes. 
2. Nanoparticle characterization 
Size, shape and surface chemistry are all important properties for determining the specific 
properties and characteristics of NPs. The morphology and size distribution of HGNs and 
PEG-HGNs were characterized by transmission electron microscopy (T20-FEI Tecnai 
thermoionic transmission electron microscope) operated at 200 kV with a LaB6 electron 
source fitted with a “SuperTwin®” objective lens allowing a point-to-point resolution of 2.4 
Å. From the TEM images, an average particle diameter was obtained for HGNs and PEG-
HGNs with ImageJ software (NIH-RSB). Using UV-VIS spectroscopy (Jasco V670) the 
characteristic plasmon at a particular wavelength of HGNs and PEG-HGNs was evaluated, 
and related with their size and shape. 
Thermogravimetric analysis (TGA; Mettler Toledo TGA/STDA 851e) was carried out in a 
temperature range between 30 and 850 ºC with a heating rate of 20 ºC/min to assess the 
PEG/Au weight ratio in the NPs. In order to analyze the stability and the surface charge of 
the particles, zeta potential assay at pH=7 was also performed (Brookhaven 90 plus and 
ZetaPALS software). The NPs were resuspended and measured in a 1mM KCl solution at a 
pH=7. Finally, X-ray photoelectron spectroscopy (XPS) was used to determine the 
elemental composition and the surface grafting of PEG-HGNs. It was performed with an 
Axis Supra (Kratos Tech.). The spectra were collected by using a monochromatized AlKa 
source (1486.6 e.V) run at 15 kV and 15 mA. For the individual peak regions, a pass energy 
of 20 eV. was used. Analyses of the peaks were performed with the CasaXPS software, 
using a weighted sum of Lorentzian and Gaussian component curves after background 
subtraction. 
3. Cell culture conditions 
Murine MSCs, human dermal fibroblasts and HeLa cells were obtained from Lonza and 
Cancer Research-UK cell services. MSCs were cultured in Dulbecco’s modified Eagle’s F-12 
medium (DMEM F-12, GIBCO) with 10% fetal bovine serum (FBS, GIBCO), 1% 
penicillin/streptomycin and 1% amphotericin and maintained at 37°C in a 5% CO2-
humidified atmosphere under hypoxic conditions (3% O2). For culturing fibroblasts and 
HeLa cells Dulbecco’s modified Eagle’s medium (DMEM, GIBCO) with 10% fetal bovine 
serum (FBS, GIBCO), 1% penicillin/streptomycin and 1% amphotericin were used under 
normoxic conditions.  
4. Nanoparticles cellular uptake  
Confocal microscopy characterization (Spectral Confocal Microscope Leica TCA SP2) was 
carried out to evaluate the cellular uptake and trafficking of PEG-HGNs in the different cell 
types. Cells were seeded at a density of 2 x 104 cells onto 20 mm cover slips (in a 24-well 
plate) and allowed to grow for 24 h. The PEG-HGNs (50 μg mL-1) were incubated with the 
different cellular types during one day. After that, cells were fixed with para-formaldehyde 
4% and marked with phalloidin-Alexa488 (Invitrogen) to label the cytoplasmic actin and 
with Draq-5 to label the nuclei. PEG-HGNs-based agglomerates were directly observed by 
reflection of the incident light in the confocal microscope at 488/490 nm 
excitation/emission wavelengths. Z-stack orthogonal projections were carried out in order 
to analyze the presence of PEG-HGNs inside the cytosol. 
5. Scratch assay 
To study the role of PEG-HGNs in cell migration scratch assays were carried out. First, 2 x 
105 cells (MSCs, fibroblasts and HeLa) were seeded onto 6 multi-well culture plates and 24 
h later 50 µg mL-1 of PEG-HGNs was added to the cells. The control wells were maintained 
without nanoparticles. When a homogenous monolayer of cells was achieved, a 1 mm 
wide straight line indentation was made with a 1000 µL pipette tip simulating a wound. 
Cells were washed twice with PBS and visualized in an inverted optical microscope 
(Olympus IX81) at 0h, 4h and 24 h after scratching. The data were statistically analyzed 
taking five independent measurements in three different zones of the wound.  
6. Immunoassay and confocal microscopy 
Tubulin and actin expression in MSCs, fibroblasts and HeLa cells was evaluated by confocal 
microscopy. First, cells were seeded onto 20 mm sterile cover slips (in a 24-well plate) at a 
density of 2 x 104 cells per well and allowed to grow during 24 h. After that time, PEG-
HGNs were added to the cells at a concentration of 50 µg mL-1 keeping the incubation for 
24 h. Subsequently, cells were washed three times with PBS and fixed with para-formaldehyde 
4% during 20 minutes. 
The immunoassay was done as follows: cells were permeabilized with 0,1% PBS-BSA 
saponin. Afterward, they were incubated for 1 h at room temperature in a wet chamber 
with the specific antibodies. For actin labeling, a phaloidin-Alexa488 (Invitrogen) was used. 
In the case of tubulin, not only a primary antibody against α-tubulin (Invitrogen) was 
employed, but also an immunofluorescence-conjugated secondary antibody (Zymed 
Laboratories) was needed. In that case, a pre-blocking with 5% PBS-BSA was performed. 
Next, the cover-slips were mounted in the holders with mowiol containing Draq5 and 
visualized by confocal laser scanning microscopy (Spectral Confocal Microscope Leica TCA 
SP2). Finally, the fluorescence intensity, corresponding with the protein expression level, 
was measured using Confocal Uniovi ImageJ software (NIH-RSB). 
7. Cell cycle evaluation 
To study the effect of HGNs on the proliferation rate of the different cell types, the 
distribution of cell-cycle phases after NPs treatment was assessed by flow cytometry. First 
of all, cells were seeded onto 6-well plates at a density of 2,5 x 105 cells per well. After 24 h 
of maintenance, PEG-HGNs (50 μg mL-1) were added into the treated wells. One day later, 
cells were trypsinized and washed twice with PBS (1200 rpm, 5 min). Finally, cells were 
collected in PBS and fixed with 70% ice-cold ethanol (1 x 106 cells per mL) and maintained 
at 4 ºC in these solution almost for 24 h. DNA staining was performed by adding RNase A 
and propidium iodide to the cell solution. Finally, samples were analyzed in a FACSARRAY 
BD equipment with the MODIFIT 3.0 Verity software. Control samples (not treated cells) 
were also run to know the standard distribution of cell cycle in the cell lines assayed. 
8. Mesenchymal stem cells differentiation 
The adipogenic and osteogenic differentiation capacity of MSCs was evaluated in presence 
or absence of PEG-HGNs. Briefly, cells were allowed to grow until the appropriate 
confluence and the different induction medium was added. On the one hand, induction 
adipogenic medium (Stem Cells Technologies) was changed every 2-3 days. Cells were 
maintained in that medium during 14 days. The final concentration of PEG-HGNs in the 
culture was 50 µg mL-1. At the end of the experiment cells were recovered for RNA 
extraction. On the other hand, osteogenic induction medium (R&D systems supplements) 
was also changed every 2-3 days keeping the same final PEG-HGNs concentration (50 µg 
mL-1). In that case cells were cultured with the induction medium for 21 days. After that 
time total RNA was purified from the cells. 
9. Real time PCR 
The total RNA was isolated from mesenchymal stem cells treated or not with PEG-HGNs 
during the osteogenic or adipogenic differentiation induction experiments. Reverse 
transcription was performed using the PrimeScript™ Reverse Transcriptase kit (Takara). The 
relative mRNA expression of the osteogenic differentiation marker genes was normalized 
to the GADPH gene and expressed as a fold change relative to the undifferentiated 
control. Calculations of quantification relative to gene expression were carried out using 
the 2ΔΔCt method[21]. The 2ΔΔCt method expresses the proportion obtained from the 
relationship between the Ct values of the sample of interest and the Ct values of the 
control sample as expressed in the following equation: 
Induction, relative quantity (RQ): 2 [ΔCt (sample) - ΔCt (calibrator)] 
ΔCt (sample) = Ct (H)m - Ct (P)m 
ΔCt (calibrator) = Ct (H)c - Ct (P)c 
The polymerase chain reaction (PCR) conditions were: an initial step at 95°C for 30 
seconds, 40 denaturation cycles of 95°C for 5 seconds and annealing at 60°C for 34 
seconds. The following table shows the nucleotidic sequence of the studied genes. 























10. Scaffold colonization 
 
In order to probe that MSCs incubated with PEG-HGNs (50 µg mL-1) were able to colonize 
different scaffolds, they were seed onto fibrin or polycaprolactone (PCL) scaffolds. Fibrin 
scaffolds were prepared following our previous report[22]. Polycaprolactone scaffolds were 
prepared by electrospinning using an Yflow 2.2.D-500 electrospinner (Electrospinning 
Machines/R&D Microencapsulation, Malaga, Spain). In brief PCL pellets were dissolved in 
DCM/DMF (1:1) and the solution was stirred overnight. The polymer solution was then 
electrospun using a voltage of 10.25 kV. The flow rate and the spinning distance were fixed 
to 0.5 mL/h and 19 cm., respectively. The spun fibers were collected on a static plate 
(covered with aluminum foil) connected to negative voltage power supply, at a voltage of 
3.11 kV for 18 hours. 
Briefly, 4 x 104 of control cells or cells incubated with PEG-HGNs were seeded in the center 
of PCL membranes (into MW-24 culture plates). One hour later, 600 µL of culture medium 
were added to each well. Then, cells were incubated during 24 h more. Next, PCL 
membranes were fixed with 4% paraformaldehyde during 20 min at room temperature. 
After two washing cycles with PBS the membranes were placed on a microscopy slide and 
cell nuclei were stained with Draq5 diluted in Mowiol. Subsequently, a cover was placed 
on the membranes for facilitating visualization by confocal microscopy. Samples were 
observed on a Leica TCA SP2 confocal microscope. In all cases, Z acquisitions of different 
sample areas were performed in order to visualize different planes of the membrane. 
In parallel, 3,75 x 104 control or pre-incubated with NPs (50 µg mL-1) MSCs were seeded 
onto fibrin gels. In this case the MSCs employed were able to express the GFP protein, 
which facilitated their visualization by fluorescence microscopy. The GFP positive cells 
were kindly provided by Rebeca González. In this experiment, different planes of the gels 
were acquired at different times in a multidimensional microscope with real time control 
Leica AF6000 LX, which allowed visualizing the in vivo colonization of the gel. 
 
11. Statistical analysis 
All the data was expressed as the mean ± standard deviation and all the experiments were 
performed in triplicate. The statistical analysis of the data with normal distribution was 
performed using the Student’s t-test and one way analysis of variance using software 
Stata/SE 12.0. For the data groups with a non-normal distribution, the Wilkonson Rank 
Sum test and the Kruskal-Wallis test were employed. p<0,05 was considered statistically 
significant. 
 




Figure 1 shows TEM images of the as-prepared nanoparticles. The morphology of the 
obtained nanoparticles was pseudo-spherical with a thick shell visualized in the TEM 
images as a dark ring. The functionalization with PEG resulted in an external polymeric 
shell as a halo of almost 4 nm surrounding the HGNs (Figure 1, top, far right). After 
pegylation no changes in the morphology or the stability of the nanoparticles were 
observed. The mean size of HGNs was 38.01 ± 5.4 nm, while of PEG-HGNs was 41.7 ± 4.4 
nm. A maximum absorbance peak was observed in the NIR region, precisely at 808 nm, 
which corresponds with the geometrical shape and size observed in TEM images according 
to the literature[23]. At pH=7 the surface charge of the HGNs and the PEG-HGNs, measured 
by DLS, was -12.63 ± 0.66 and -7.51± 1.53, respectively. TGA analysis (Figure 1c) showed 
that the quantity of PEG in the functionalized nanoparticles was around 30% of the total 
nanoparticle mass. XPS analysis (Figure 2) revealed that in addition to gold oxygen and 
carbon were also present on the surface even in HGNs, which was mainly attributed to the 
presence of PVP on the surfaces in agreement with our TGA results (Figure 1c) where 
approx. a 20 % of the nanoparticle weigh corresponds to organic matter. The PEG used for 
the functionalization contained sulfur due to the presence of the thiol group in the 
molecule. This sulfur was also observed in PEG-HGNs, and can be used to trace the 
presence of PEG on the particles. Also, the chemical environment of gold and sulfur atoms 
can be studied to assess the chemical bonding between PEG and the gold NPs. A peak 
displacement to higher binding energies was observed in the chemical environment of 
gold, possibly due to union between gold and sulfur. This suggests that the interaction 
between PEG and HGNs occurs thank to a gold-sulfur bond. We also observed that almost 
the 90% of the gold was linked to the sulfur. This is consistent with previously published 
results[24]. 
 
Nanoparticle cytotoxicity and uptake 
 
The AlamarBlue® analysis showed that PEG-HNGs did not decrease cell viability at the 
studied doses (10, 20, 50, 100 and 200 μg mL-1) in any of the cell types of interest (MSCs, 
HeLa and fibroblasts). In contrast, a dose-dependent cell viability decrease was observed 
for the non-pegylated HGNs with a marked cytotoxicity at doses above 100 µg mL-1 after 
24 h of contact for the three cellular types (Figure 3). The dose of 50 µg mL-1 PEG-HGNs 
was chosen for the next experiments as the limit of sub-cytotoxic dose. These results are 
in agreement with previous studies demonstrating that nanoparticle cytotoxicity was 
reduced after pegylation[25]. 
 
Nanoparticle uptake is influenced by factors such as the physical properties (e.g. size, 
surface charge) of the nanomaterial or variations in cell-membrane characteristics[26,27]. 
Confocal microscopy experiments showed large amounts of PEG-HGNs clearly internalized 
in MSCs forming aggregates inside vesicles (shown as red-colored agglomerates in Figure 
4), probably following the endosomal route. Moreover, these NPs were only distributed in 
the cytoplasm rather than in the nuclei of MSCs because of their size[28],[29]. Unlike MSCs, a 
significantly lower accumulation of PEG-HGNs was observed inside fibroblast or HeLa cells. 
It is important to point out that cells were washed before observation, hence any non-
internalized nanoparticle would be washed away and only the internalized ones can be 
observed. 
 
Nanoparticle influence on cell properties 
 
a) Migration evaluation 
 
A variety of physiological and pathological processes such as embryonic 
development, blood vessel formation and remodeling, tissue regeneration, immune 
surveillance and inflammation are strongly dependent on the cell migration mechanism[30]. 
In order to study the capacity of PEG-HGNs as modifiers of cellular behavior for either 
stem-cell based strategies, or regenerative medicine, some comparative migration 
experiments were performed following the scratch assay after incubating the three cell 
types tested with PEG-HGNs during 24h. The assay revealed that PEG-HGNs only 
significantly influenced MSCs migration but not the other cell types studied. On MSCs, they 
caused a clear increase in the migration rate compared to untreated cells (p < 0.05) (Figure 
5). The untreated cells reached a 65% of wound closure 24 h after the scratch, whereas 
cells treated with NPs closed almost 90% of the bare surface. However, migration in HeLa 
cells and fibroblasts was not clearly affected and their migration capacity was significantly 
smaller than the migration rate of MSCs at 24 h (Figure 5). These results can be explained 
at least in part by the fact that PEG-HGNs were readily internalized by MSCs, but not by 
the other cell types. In addition, the limitation of plate adhesion was ruled out as a 
possible cause of migration induction, since the effect was only observed in MSCs. To test 
this, the expression of an adhesion rule protein (vinculin) was studied, without any 
observed effect on that expression. The expression of proteins involved in cell adhesion 
and migration such as actin, tubulin and vinculin[31] was studied in cells incubated with 
PEG-HGNs and control cells. The immunoassay revealed that MSCs incubated with PEG-
HGNs showed an increased expression rate of actin and tubulin with respect to control 
cells, being this expression almost 4 times higher (Figure 6). On the other hand, the 
vinculin expression was not affected. Here, we propose that the increment observed in the 
closure’s speed was probably due to this enhancement in the actin and tubulin expression. 
It is important to remark that the expression level of the two structural proteins studied 
(actin and tubulin) in the different cellular types treated with PEG-HGNs was analyzed by 
quantifying their fluorescence level using the confocal microscopy and the appropriate 
software to analyze fluorescence. In order to compare the protein expression levels, all the 
samples were observed under the same optical conditions as the control. On the contrary, 
both fibroblast and HeLa cells treated with PEG-HGNs showed a similar tubulin and actin 
expression compared to the control. Therefore, only those cellular types capable to 
significantly internalize PEG-HGNs increased their migration rate via an increment in actin 
and tubulin expression. These results are highly promising because cells involved in 
regeneration such as MSCs, were able to internalize the NPs studied, while the tumoral 
cells studied here (HeLa) did not show any increase in their migration capacity. While most 
of the published results today regarding the effects of nanoparticles in scenarios relevant 
to regenerative medicine show limitations or inhibition of cell migration and 
proliferation[14],[32],[33], the results of this work evidence the potential of HGNs as 
performance enhancers in stem-cell based strategies. 
b) Proliferation evaluation by cell cycle analysis 
No significant differences were found in the cell cycle phase percentages for MSCs or HeLa 
cells when treated with PEG-HGNs compared to the control (Figure 7). Consequently, we 
can conclude that the arrest of cell cycle or the damage in the DNA was not induced by 
PEG-HGNs at the studied doses in these cellular types. Only in human dermal fibroblast, 
the G1 phase was markedly diminished while the S phase was increased. The affection of 
the cell cycle is greatly dependent of cellular and nanomaterial type. Uz et al.[34] have 
recently described that different GNPs with varying degrees of PEG grafting density may 
affect the cell cycle in different manners. Also it was reported that titanium nanoparticles 
might affect the MSCs cell cycle in a negative way by increasing the G1 phase and 
decreasing the G2 and S phases[33]. 
 
c) MSCs differentiation studies 
MSCs differentiation is a key step in various tissue regeneration processes, such as bone 
formation. However, the reports on the influence of GNPs on the differentiation process 
are scarce and their mechanism of action is still under debate. Some studies have shown 
that GNPs enhance osteogenic differentiation and decrease adipogenic 
differentiation[19,35]. Li et al.[36] proposed that different gold nanospheres might provide 
mechanical signals that increase YAP activity and consequently induce osteogenic gene 
expression, as Runx2. The same research showed that larger spheres, stars or rods did not 
affect cell differentiation and 40 nm nanorods even reduced the YAP activity. Zhang et 
al.[37] described the stimulation of the ERK/MAPK signaling pathway in primary osteoblasts 
mediated by GNPs. Also Wan-Kyu et al.[11] reported the positive effect of different sizes of 
GNPs in osteogenic differentiation, as well as Yi et al.[38] who concluded that the 
mechanism involved in the differentiation promoted by 20 nm GNPs was the p38 MAPK 
pathway modification.  
In our study, real time PCR results showed that Runx2 expression was increased in 
MSCs incubated with PEG-HGNs and differentiated to osteoblasts, compared to the 
negative control, to a greater extent compared to differentiated MSCs without NPs (Figure 
8). Since it has been described[37,39] that Runx2 is regulated by MAPK pathway, we propose 
that PEG-HGNs might interact with this protein cascade and therefore acting by a 
mechanical stimulus.  
d) Scaffolds colonization 
  For an initial assessment of the potential application of the MSCs / PEG-HGNs 
combination in regenerative medicine, the ability of these cells to colonize different types 
of scaffolds was studied. As can be seen in Figure 9, both control MSCs and those that had 
been cultured in the presence of PEG-HGNs were able to colonize the PCL scaffold 
efficiently 24 h after seeding. Qualitatively, cells pre-incubated with PEG-HGNs colonized 
the scaffold more homogeneously than control cells, as indicated by the greater number 
and better distribution of nuclei visible in similar areas of the scaffold. 
  Colonization studies of fibrin scaffolds were also carried out. In this case the ability 
of cells incubated or not with NPs to colonize fibrin scaffolds with or without NPs (Figure 9) 
was analyzed. In all cases an efficient colonization of the different gels was observed. The 
improvement in cell viability and proliferation mediated by the addition of GNPs to 
scaffolds has recently been reported. They probed that the attachment of GNPs and 
hydroxyapatite NPs to scaffolds improved the proliferation and viability of fibroblast. They 
proposed that the observed proliferation increase may be due to the high surface energy 
of NPs that could affect protein adsorption. Protein adsorption influences cell response to 
nanoparticles and may enhance cell proliferation[40]. On the other hand, Baranes et al.[41] 
observed the beneficial effect of GNPs on the differentiation, proliferation and maturation 
of cultured neurons on 3D scaffolds. In this case the addition of GNPs provided additional 
anchor sites that allowed for greater morphogenesis. In accordance with that study, the 
role of GNPs needs to be more investigated, in order to determine whether the NPs 
promote axon elongation and higher expression of neuronal markers due to topographical 
cues or due to their conductivity. 
 Here, we demonstrated that MSCs containing PEG-HGNs are able to successfully 
colonize fibrin and PCL-based scaffolds being the NPs responsible for a faster migration 
rate compared to the control cells as seen in the scratch assay. In addition, an enhanced 
osteoblastic differentiation also highlights the potential use of nanoparticle-laden cells in 




HGNs have been used in different biomedical applications as heat transducers in 
tumor photothermia treatments. Nevertheless, their use as promoters in regenerative 
medicine has not been studied in depth. The results here proposed are very promising 
because PEG-HGNs are able to induce MSCs migration whereas this effect is not observed 
in tumoral cells. Also the enhancement in osteogenic differentiation could open new 
horizons for the use of PEG-HGNs in the design of biomaterials as scaffolds for bone 
regeneration. Although more studies are still necessary, our data provide evidence of the 
possibility of combining MSCs and HGNs in the development of new materials with 
possible application in regenerative medicine. 
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Figure 1. HGNs and PEG-HGNs characterization. a) TEM images of HGNs and PEG-HGNs. PEG 
functionalization is clearly visible around the nanospheres. b) UV-Vis absorption spectra for both types 




   
 
Figure 2. XPS of HGNs and PEG-HGNs. a) Elemental composition of HGNs and PEG-HGNs. b) Binding 
energies and peak assignation for S2p 3/2 and Au 4f 7/2 core levels  PEG-HGNs; c) Au 4f core level 
spectrum. The blue line indicates the binding energies of the elemental gold and the red line indicates 














Figure 3. Cytotoxicity analysis. AlamarBlue® results for a) MSCs; b) HeLa cells; and c) human dermal 






Figure 4. HGNs and PEG-HGNs internalization evaluation by confocal microscopy. In order 
to visualize the cytoplasm of the cells, the actin was labeled with phalloidin-488, whereas the nuclei 
were stained with Draq5. PEG-HGNs were directly visualized by reflection. In all cases, a Z-stack was 
done to confirm the internalization of the particles. PEG-HGNs agglomerates were only observed inside 




Figure 5. Migration evaluation. a) Scratch assay in MSCs, HeLa cells and fibroblasts incubated 
without (control) or with PEG-HGNs (50 μg mL-1) evaluated by inverted optical microscope.                 
(Scale bar = 500 µm). b) Quantitative analysis of relative cell migration for 0, 4 and 24 h. The differences 
between the closed surface at different intervals of time are shown. Significant differences (p<0.05) 











Figure 6. Actin and tubulin expression evaluation. a) Immunoassay study for proteins by 
confocal microscopy. Actin was labeled with phalloidine-488 and tubulin and vinculin were marked with 
and specific antibody. (Scale bar = 47.7 µm). b) Relative fluoresce intensity analysis of actin, tubulin and 
vinculin in the three cellular types. Significant differences between the control and the treated cells 














Figure 7. Cell cycle analysis. The three cellular types were incubated with PEG-HGNs at a 























Figure 8. Differentiation evaluation. The images represent the typical staining for osteogenic 
(Alizarin Red) and adipogenic (Oil Red) differentiation. The graph shows gene expression of osteogenic 












   
 
Figure 9. Scaffold colonization. a) PCL membranes colonization by control cells or cells with 
internalized PEG-HGNs 24 h after seeding the cells. Scale bar: 47,6 µm. b) Fibrin scaffold colonization by 
MSCs incubated with or without PEG-HGNs. In the first row the photos show control cells seeded onto 
control scaffolds. The second row represents control scaffold colonization by cells incubated with PEG-
HGNs. The third row shows the colonization of a fibrin gel with PEG-HGNs by control cells. In the last 
row both the cells and the gel contained PEG-HGNs. Scale bar: 254 µm. 
 
